In search of cerebrospinal fluid biomarkers of fatigue in multiple sclerosis: A proteomics study.
Saved in:
| Title: | In search of cerebrospinal fluid biomarkers of fatigue in multiple sclerosis: A proteomics study. |
|---|---|
| Authors: | Valko PO; Department of Neurology, University Hospital Zurich, University of Zurich, Zurich, Switzerland., Roschitzki B; Functional Genomics Center Zurich, University of Zurich/ETH Zurich, Zurich, Switzerland., Faigle W; Department of Neurology, University Hospital Zurich, University of Zurich, Zurich, Switzerland., Grossmann J; Functional Genomics Center Zurich, University of Zurich/ETH Zurich, Zurich, Switzerland., Panse C; Functional Genomics Center Zurich, University of Zurich/ETH Zurich, Zurich, Switzerland., Biro P; Department of Anesthesiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland., Dambach M; Department of Anesthesiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland., Spahn DR; Department of Anesthesiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland., Weller M; Department of Neurology, University Hospital Zurich, University of Zurich, Zurich, Switzerland., Martin R; Department of Neurology, University Hospital Zurich, University of Zurich, Zurich, Switzerland., Baumann CR; Department of Neurology, University Hospital Zurich, University of Zurich, Zurich, Switzerland. |
| Source: | Journal of sleep research [J Sleep Res] 2019 Jun; Vol. 28 (3), pp. e12721. Date of Electronic Publication: 2018 Jul 01. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Published on behalf of the European Sleep Research Society by Blackwell Scientific Publications Country of Publication: England NLM ID: 9214441 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2869 (Electronic) Linking ISSN: 09621105 NLM ISO Abbreviation: J Sleep Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
